Equity Overview
Price & Market Data
Price: $4.03
Daily Change: $0.00 / 0.00%
Daily Range: $3.86 - $4.41
Market Cap: $262,191,776
Daily Volume: 838,327
Performance Metrics
1 Week: -3.36%
1 Month: -27.91%
3 Months: -39.40%
6 Months: -34.47%
1 Year: -67.02%
YTD: -39.40%
Company Details
Employees: 334
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.